Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.099 | 0.04 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.094 | 0.04 |
mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.04 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.04 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.33 | 0.05 |